This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
hours. There were no reports of patients excluded for any reason. There was no evidence of whether the study sample was representative of the study population.
Study design
The analysis was based on a retrospective cohort study, with data gathered from medical records. Patients were assigned to the two groups according to the antibiotic regimen they received, which depended on the surgeon's preferences. The study was carried out at a single centre, the Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, (PA). Each patient was followed up until the first clinic visit, usually 1 to 2 weeks after discharge.
Analysis of effectiveness
The analysis was conducted on the basis of the actual antibiotic regimen received. The primary health outcomes were the overall complication rates and the numbers of patients experiencing antibiotic-related complications and readmissions. The groups were reported to be comparable at baseline in terms of their age, gender, duration of presenting symptoms, initial white blood cell count and length of hospitalisation.
Effectiveness results
The overall complication rate was 8% in the PT group and 32% in the MD group.
Patients in the MD group were more likely to suffer from a complication than those in the PT group, (14 of 43 MD patients versus 4 of 51 PT patients; p=0.002), and more likely to suffer from an antibiotic complication (10 of 43 MD patients versus 4 of 51 PT patients; p=0.04).
There were no statistically significant differences in the number of patients readmitted (4 MD patients versus 1 PT patient, p=0.17).
Clinical conclusions
Monotherapy would appear to be more effective in the treatment of children with perforated appendicitis. It resulted in a significantly lower number of patients experiencing overall complications and antibiotic-related complications than those treated with MD therapy.
Measure of benefits used in the economic analysis
The authors did not estimate a summary measure of benefits. The study was therefore categorised as a costconsequences analysis.
Direct costs
The authors did not report the perspective adopted, although they appear to have been concerned with the costs to the heath care provider or third-party payer as they were interested in inpatient and outpatient charges. However, it was unclear whether overheads and similar costs element relevant to these perspectives were included. The costs were derived from actual patient records and authors' assumptions about the duration of home antibiotics (based on that presented by the most common home care agency employed in the study setting). Charges taken from the accounting department at the study setting were used instead of unit costs; a cost-to-charge adjustment was not performed. As the time horizon for each patient was short, discounting was not necessary in this study. A price year and any attempts to reflate prices were not reported to have been used. The total price was not broken down beyond total inpatient and outpatient charges.
Indirect Costs
The indirect costs were not estimated.
Currency

US dollars ($).
Sensitivity analysis
There was no report of sensitivity analyses being carried out to estimate the impact of uncertainty on the results.
Estimated benefits used in the economic analysis
See the 'Effectiveness Results' section.
Cost results
For the PT group, the total average inpatient charges were $19,191 (standard deviation, SD=7,433) and the outpatient charges were $2,460.
For the MD group, the total average inpatient charges were $20,703 (SD=11,306) and the outpatient charges were $4,349.
The difference in inpatient charges between the study groups was not significant, (p=0.5)
Synthesis of costs and benefits
Not relevant.
Authors' conclusions
Monotherapy would appear to be more effective and more cost-effective than multi-drug (MD) therapy (at least in the outpatient setting) since it reduced complications without significant differences in charges.
CRD COMMENTARY -Selection of comparators
MD therapy was reported to be standard practice in the study setting, although the authors commented that recent evidence demonstrating the benefits of PT prompted a protocol of PT to be adopted. The authors' choice of technologies enabled a real world comparison relevant to their own setting to be adopted. You should decide if the treatments considered in the study are relevant treatments for children with perforated appendicitis in your own setting.
Validity of estimate of measure of effectiveness
The analysis was based on a retrospective cohort study of patients, with the grouping determined by the surgeon. This non-randomisation and selection according to preferences introduces the possibility of selection bias, and thus can lead to substantial within-group similarities and between-group variation. However, comparisons of the groups at baseline suggested that patients in the two groups were comparable at baseline. One limitation the authors highlighted was the limited sample size, which reduces the ability to detect statistically significant results. An interesting supplement to the study would have been to identify the surgeons' reasons for assigning patients to each of the groups. The study sample might have been representative of the study population as it comprised all children entering the study setting and receiving antibiotic treatment following perforated appendicitis. The sample was reported to be consistent with those assessed in similar studies. Statistical analyses were carried out to compare the individuals at baseline and the study outcomes.
